A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
The UK government is reported to be trying to restart talks over drug pricing and rebates after MSD's shock decision to scrap a £1 billion investment programme. According to the Financial Times, ...
If there’s one warning light that unites every driver from Anchorage to Miami, it’s that little amber engine icon.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback